The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity - Probing the role of the methionine-turn in the metzincin metalloprotease superfamily

被引:38
作者
Butler, GS
Tam, EM
Overall, CM
机构
[1] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada
关键词
D O I
10.1074/jbc.M312727200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) are an important family of extracellular proteases that process a variety of biologically significant molecules. MMPs are members of the metzincin superfamily of >770 zinc endopeptidases, which includes astacins, serralysins, adamalysins, leishmanolysins, and snapalysins. Metzincins are characterized by an absolutely conserved methionine residue COOH-terminal to the third histidine in the consensus sequence HEXXHXXGXX(H/D), where the histidine residues chelate a catalytic zinc ion. The canonical methionine is part of a tight 1,4-beta-turn that loops the polypeptide chain beneath the catalytic zinc ion, forming a hydrophobic floor to the Zn2+ ion binding site. The role of this methionine is uncertain, but its absolute conservation indicates an essential catalytic or structural function. To investigate this hypothesis, we replaced Met-392 that forms the Met-turn of human MMP-2 (gelatinase A) by site-directed mutagenesis. The catalytic competence of leucine and serine mutants was assessed. (M392L) MMP-2 and (M392S) MMP-2 cleaved the physiological substrates gelatin, native type I collagen, and the chemokine monocyte chemoattractant protein-3 with similar efficiency to wild-type MMP-2. These mutants also cleaved two quenched fluorescent peptide substrates with a k(cat)/K-m comparable to wild-type MMP-2 and underwent 4-aminophenylmercuric acetate-induced autoactivation with similar kinetics. (M392L) MMP-2 and (M392S) MMP-2 were inhibited by tissue inhibitor of metalloproteinases (TIMP)-1, -2, and -4 and by the zinc chelators 1,10-phenanthroline and a synthetic hydroxamate inhibitor, Batimastat, similar to the wild-type protein, indicating an unaltered active site topography. A tryptic susceptibility assay also suggested that (M392L) MMP-2 and (M392S) MMP-2 were correctly folded. These results challenge the dogma that this methionine residue and the Met-turn, which are absolutely conserved in all of the subfamilies of the metzincins, play an essential role in catalysis or active site structure.
引用
收藏
页码:15615 / 15620
页数:6
相关论文
共 38 条
[1]   Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].
Atkinson, SJ ;
Crabbe, T ;
Cowell, S ;
Ward, RV ;
Butler, MJ ;
Sato, H ;
Seiki, M ;
Reynolds, JJ ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485
[2]   Loss of collagenase-2 confers increased skin tumor susceptibility to male mice [J].
Balbín, M ;
Fueyo, A ;
Tester, AM ;
Pendás, AM ;
Pitiot, AS ;
Astudillo, A ;
Overall, CM ;
Shapiro, SD ;
López-Otín, C .
NATURE GENETICS, 2003, 35 (03) :252-257
[3]  
Bigg HF, 2001, CANCER RES, V61, P3610
[4]   Structural properties of matrix metalloproteinases [J].
Bode, W ;
Fernandez-Catalan, C ;
Tschesche, H ;
Grams, F ;
Nagase, H ;
Maskos, K .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (04) :639-652
[5]   ASTACINS, SERRALYSINS, SNAKE-VENOM AND MATRIX METALLOPROTEINASES EXHIBIT IDENTICAL ZINC-BINDING ENVIRONMENTS (HEXXHXXGXXH AND MET-TURN) AND TOPOLOGIES AND SHOULD BE GROUPED INTO A COMMON FAMILY, THE METZINCINS [J].
BODE, W ;
GOMISRUTH, FX ;
STOCKLER, W .
FEBS LETTERS, 1993, 331 (1-2) :134-140
[6]   Mannose-binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis - Potential role in human MBL deficiency [J].
Butler, GS ;
Sim, D ;
Tam, E ;
Devine, D ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :17511-17519
[7]   Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases [J].
Cawson, T .
MOLECULAR MEDICINE TODAY, 1998, 4 (03) :130-137
[8]   Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis [J].
Curran, S ;
Murray, GI .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) :1621-1630
[9]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[10]   Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects [J].
Fingleton, B .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (03) :385-397